NEWS from REP. ROB BRESNAHAN

Bresnahan pushes for prior authorization reform in Congress

Posted 9/30/26

WASHINGTON, DC — On  Wednesday, September 30, U.S. Representative Rob Bresnahan, Jr. (PA-08) announced that he cosponsored several pieces of legislation targeted at improving accountability …

This item is available in full to subscribers.

Please log in to continue

Log in
NEWS from REP. ROB BRESNAHAN

Bresnahan pushes for prior authorization reform in Congress

Posted

WASHINGTON, DC — On  Wednesday, September 30, U.S. Representative Rob Bresnahan, Jr. (PA-08) announced that he cosponsored several pieces of legislation targeted at improving accountability from insurance companies and protect patients from unnecessary delays in care. 

“Insurance companies have a responsibility to manage healthcare costs, but that should never mean putting profits ahead of patients,” said Bresnahan. “Families pay their premiums every month and shouldn’t have to fight with an insurance company to get the care their doctor says they need. We need reforms that cut red tape, hold insurance companies accountable, and make sure medical decisions are driven by doctors and patients, not the bottom line.”

Prior authorization is intended to help insurers manage costs and ensure certain treatments meet coverage requirements, but the process has led to significant administrative and access challenges. In a 2024 American Medical Association survey, 94% of physicians said prior authorization delays access to necessary care, while physicians reporting spending an average of 12 hours per week completing prior authorization requests. Additionally, a 2022 HHS Office of Inspector General review found that 13% of sampled Medicare Advantage prior authorization denials met Medicare coverage rules, meaning those services likely would have been approved under traditional Medicare.

“Insurance companies operate in a multibillion-dollar market, but patients are not dollar signs,” continued Bresnahan. “Doctors should not have to spend hours fighting with insurers over treatments they have already determined are medically necessary. We can protect taxpayer and premium dollars without letting insurance companies put profits ahead of care. Prior authorization reform is about putting patients first and giving doctors the ability to do their jobs.”

To combat the delays in necessary care, contributions to patients abandoning recommended treatment, and added time from doctors and their staff, Rep. Bresnahan cosponsored:

  • H.R. 3514, Improving Seniors’ Timely Access to Care Act of 2025, which establishes requirements for prior authorization in Medicare Advantage, including electronic prior authorization, faster decision timelines, transparency requirements, and greater accountability for MA plans.
  • H.R. 2433, Reducing Medically Unnecessary Delays in Care Act of 2025, which establishes stricter federal standards for prior authorization decisions made by Medicare contractors and private Medicare plans. This bill mandates that coverage denials must be based on clear, evidence-based clinical criteria developed with input from practicing physicians. Furthermore, it requires plans to post their authorization rules online, provide advance notice of changes, and publicly report approval and denial statistics. Finally, all final denials of care must be reviewed and issued by a qualified, board-certified physician.
  • H.R. 9396, Prior Authorization Accountability Act, which requires insurers that use prior authorization to publicly disclose approval and denial rates, appeal volumes and outcomes, average and median decision times, and the percentage of decisions made using AI or other specified technology.
  • H.R. 9734, Protecting Patients from Automated Denials Act, which establishes requirements for the use of artificial intelligence in prior authorization denials by Medicare Advantage organizations.
  • H.R. 9192, Prior Authorization Reform for Autoimmune and Blood Disorders Act, which addresses insurance coverage and prior authorization barriers involving drugs for autoimmune diseases and certain blood disorders.
Bresnahan, prior authorization

Comments

No comments on this item Please log in to comment by clicking here